Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hydroa vacciniforme

R Ketterer¹, P Morier, E Frenk

¹Department of Dermatology, University Hospital, Lausanne, Switzerland.

Dermatology (Basel, Switzerland)

|January 1, 1994

Summary

This summary is machine-generated.

Hydroa vacciniforme, a childhood photodermatosis causing scarring vesicles, showed improvement in an 8-year-old boy. Treatment with chloroquine and sunscreen was effective.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Confirmation of the origin of NISCH syndrome.

Human mutation·2006

Same author

Induction of the putative protective protein ferritin by infrared radiation: implications in skin repair.

International journal of molecular medicine·2000

Same author

In vivo induction of pyrimidine dimers in human skin by UVA radiation: initiation of cell damage and/or intercellular communication?

International journal of molecular medicine·1999

Same author

Evidence that ferritin is UV inducible in human skin: part of a putative defense mechanism.

The Journal of investigative dermatology·1998

Same author

Sunlight and carcinogenesis: expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations.

International journal of cancer·1998

Same author

Erythema induction by ultraviolet radiation points to a possible acquired defense mechanism in chronically sun-exposed human skin.

Dermatology (Basel, Switzerland)·1997

Same journal

Survey on Difficult to Treat Tinea: A Sub-Saharan Africa Snapshot.

Dermatology (Basel, Switzerland)·2026

Same journal

Mpox Outbreaks Beyond Historically Endemic Regions: A Clinical Review of Vaccination Strategies and Public Health Challenges.

Dermatology (Basel, Switzerland)·2026

Same journal

Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study.

Dermatology (Basel, Switzerland)·2026

Same journal

Descriptive Analysis of DRESS Reports from EudraVigilance and DRESS Cases from the RegiSCAR-project.

Dermatology (Basel, Switzerland)·2026

Same journal

The Role of the Vagus Nerve and Its Stimulation in Modulating Inflammatory Skin Diseases and Other Dermatologic Conditions: From Mechanisms to Therapeutics.

Dermatology (Basel, Switzerland)·2026

Same journal

Skin Barrier Dysfunction, Antimicrobial Peptide Alterations, and Microbiome Changes in Solid Cancer Patients Treated with Epidermal Growth Factor Receptor Inhibitors.

Dermatology (Basel, Switzerland)·2026

See all related articles

Area of Science:

Dermatology
Pediatrics
Photomedicine

Background:

Hydroa vacciniforme is a rare, chronic photodermatosis.
It typically manifests in childhood with recurrent vesicular eruptions.
Lesions characteristically heal with scarring.

Observation:

A case study of an 8-year-old boy with typical hydroa vacciniforme symptoms is presented.
The patient exhibited recurrent vesicles and subsequent scarring.

Findings:

Favorable clinical evolution was observed in the pediatric patient.
Treatment involved the administration of chloroquine.
Concurrent use of a topical sunscreen was also part of the management strategy.

Implications:

Related Experiment Videos

Chloroquine may be a viable therapeutic option for managing hydroa vacciniforme.
Sunscreen use is crucial for mitigating photosensitivity in this condition.
Early intervention and combined treatment approaches can lead to positive outcomes in pediatric photodermatoses.